Paper40052411
ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma.
Lai X and 7 others. Cancer Sci, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma. Papers, record 40052411. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40052411
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- ATR Inhibition Synergizes With Alkylating PI Polyamide Targeting MYCN by Suppressing DNA Repair in MYCN-Amplified Neuroblastoma.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Neuroblastoma | Major topic |
| N-Myc Proto-Oncogene Protein | Major topic |
| Ataxia Telangiectasia Mutated Proteins | Major topic |
| DNA Repair | Major topic |
| Nylons | Major topic |
| Humans | |
| Animals | |
| Cell Line, Tumor | |
| Mice | |
| Xenograft Model Antitumor Assays | |
| Apoptosis | |
| Drug Synergism | |
| DNA Damage | |
| Gene Amplification | |
| Pyrroles | |
| Imidazoles | |
| Gene Expression Regulation, Neoplastic |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| JP22zf0127001 | Japan Agency for Medical Research and Development (AMED)-Moonshot | PubMed | ||
| JP23zf0127001 | Japan Agency for Medical Research and Development (AMED)-Moonshot | PubMed | ||
| JP22H04923 | JSPS KAKENHI | PubMed | ||
| JP22K07245 | JSPS KAKENHI | PubMed | ||
| Takeda Science Foundation | PubMed | |||
| JP22ek0210168 | AMED | PubMed | ||
| JPMJSP2109 | JST SPRING | PubMed |
Source PubMed
References42
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32354033 | ATR Inhibition Potentiates PARP Inhibitor Cytotoxicity in High Risk Neuroblastoma Cell Lines by Multiple Mechanisms. | Cancers (Basel) | 2020 | https://conductscience.org/library/papers/32354033 | PubMed |
| 2 | 28625637 | A randomized, phase 2 evaluation of the CHK1 inhibitor, LY2603618, administered in combination with pemetrexed and cisplatin in patients with advanced nonsquamous non-small cell lung cancer. | Lung Cancer | 2017 | https://conductscience.org/library/papers/28625637 | PubMed |
| 3 | 21173028 | MYCN sensitizes human neuroblastoma to apoptosis by HIPK2 activation through a DNA damage response. | Mol Cancer Res | 2011 | https://conductscience.org/library/papers/21173028 | PubMed |
| 4 | 31545289 | RAD54B potentiates tumor growth and predicts poor prognosis of patients with luminal A breast cancer. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/31545289 | PubMed |
| 5 | 35078817 | ATR Inhibitor AZD6738 (Ceralasertib) Exerts Antitumor Activity as a Monotherapy and in Combination with Chemotherapy and the PARP Inhibitor Olaparib. | Cancer Res | 2022 | https://conductscience.org/library/papers/35078817 | PubMed |
| 6 | 17028100 | Expression of C-terminal deleted p53 isoforms in neuroblastoma. | Nucleic Acids Res | 2006 | https://conductscience.org/library/papers/17028100 | PubMed |
| 7 | 28530640 | Genetic regulation of the RUNX transcription factor family has antitumor effects. | J Clin Invest | 2017 | https://conductscience.org/library/papers/28530640 | PubMed |
| 8 | 33585251 | MYCN Function in Neuroblastoma Development. | Front Oncol | 2020 | https://conductscience.org/library/papers/33585251 | PubMed |
| 9 | 25605849 | Phase I dose-escalation trial of checkpoint kinase 1 inhibitor MK-8776 as monotherapy and in combination with gemcitabine in patients with advanced solid tumors. | J Clin Oncol | 2015 | https://conductscience.org/library/papers/25605849 | PubMed |
| 10 | 37020276 | ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors. | BMC Cancer | 2023 | https://conductscience.org/library/papers/37020276 | PubMed |
| 11 | 26117536 | The NEIL glycosylases remove oxidized guanine lesions from telomeric and promoter quadruplex DNA structures. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/26117536 | PubMed |
| 12 | 31707688 | A phase 1 dose-escalation study of checkpoint kinase 1 (CHK1) inhibitor prexasertib in combination with p38 mitogen-activated protein kinase (p38 MAPK) inhibitor ralimetinib in patients with advanced or metastatic cancer. | Invest New Drugs | 2020 | https://conductscience.org/library/papers/31707688 | PubMed |
| 13 | 25274755 | Therapeutic strategies to inhibit MYC. | Cold Spring Harb Perspect Med | 2014 | https://conductscience.org/library/papers/25274755 | PubMed |
| 14 | 32577161 | MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. | Oncotarget | 2020 | https://conductscience.org/library/papers/32577161 | PubMed |
| 15 | 36634205 | Correction: MYCN expression induces replication stress and sensitivity to PARP inhibition in neuroblastoma. | Oncotarget | 2023 | https://conductscience.org/library/papers/36634205 | PubMed |
| 16 | 20100802 | The novel mouse Polo-like kinase 5 responds to DNA damage and localizes in the nucleolus. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20100802 | PubMed |
| 17 | 35857500 | RRM2 enhances MYCN-driven neuroblastoma formation and acts as a synergistic target with CHK1 inhibition. | Sci Adv | 2022 | https://conductscience.org/library/papers/35857500 | PubMed |
| 18 | 39395371 | Poly (ADP-ribose) polymerase inhibitor sensitized DNA damage caused by an alkylating pyrrole-imidazole polyamide targeting MYCN in neuroblastoma cells. | Biochem Biophys Res Commun | 2024 | https://conductscience.org/library/papers/39395371 | PubMed |
| 19 | 27974823 | Roles of human POLD1 and POLD3 in genome stability. | Sci Rep | 2016 | https://conductscience.org/library/papers/27974823 | PubMed |
| 20 | 28394338 | PARP inhibitors enhance replication stress and cause mitotic catastrophe in MYCN-dependent neuroblastoma. | Oncogene | 2017 | https://conductscience.org/library/papers/28394338 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42517066 | MYC in Oncogenesis and Therapeutic Implications. | MedComm (2020) | 2026 | https://conductscience.org/library/papers/42517066 | PubMed |
| 41994561 | Targeted therapies in pediatric oncology: A start. | Mol Ther Oncol | 2026 | https://conductscience.org/library/papers/41994561 | PubMed |
| 41733731 | Identification of potential clinical markers associated with prognosis of neuroblastoma. | Discov Oncol | 2026 | https://conductscience.org/library/papers/41733731 | PubMed |
| 41193393 | Targeting Wnt/β-Catenin Pathway by DNA Alkylating Pyrrole-Imidazole Polyamide in Colon Cancer. | Cancer Sci | 2026 | https://conductscience.org/library/papers/41193393 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ATM | 472 | PubTator's text mining | https://conductscience.org/library/genes/472 | NCBI Gene |
| ATR | 545 | PubTator's text mining | https://conductscience.org/library/genes/545 | NCBI Gene |
| MYCN | 4613 | PubTator's text mining | https://conductscience.org/library/genes/4613 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40052411
GET https://conductscience.org/api/papers/v1/40052411/references?page=2